||Rapid response report: summary with critical appraisal
Rapid response report (Canadian Agency for Drugs and Technologies in Health) ^A1333668
||Although acyclovir has traditionally been seen as the drug of choice in pregnancy and pediatrics, valacyclovir has the benefit of decreased dosing frequency and potential increased compliance as a result. This report aims to review recent evidence and relevant practice guidelines on the comparative effectiveness of acyclovir and valacyclovir in children with chickenpox and in pregnant women with Herpes Simplex Virus infections, chickenpox and shingles.
|General note||Title from PDF caption.|
|Bibliography note||Includes bibliographical references.|
|Source of description||Version viewed March 3, 2015.|